tirzepatide injection new market FDA Says Compounded Must Exit the Affordable Tirzepatide for Weight Loss

When uncertainty exists, cardiac evaluation should take precedence given the potentially life-threatening nature of acute coronary syndromes in this high-risk population

Taken together, current evidence indicates that while a definitive causal relationship between GLP-1 RA therapy and severe motility disorders has not been established, clinicians should remain vigilant for GI symptoms suggestive of delayed gastric emptying or obstruction

In conclusion, we found that prescription of SGLT2 inhibitors and GLP-1 RAs could be increased substantially with a clinical-level population health intervention and that evaluation could be performed using easy-to-obtain data from existing clinical reports

GuptaNAMellsJDunhamRMGrakouiAHandyJSaxenaNKet al

In diabetes education and consulting, Dr